3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
3
Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Nasopharyngeal Carcinoma
1
Melanoma
1
Locally Advanced Rectal Adenocarcinoma
1
Locally Advanced Cervical Carcinoma
1
Liver Neoplasms
1
Liver Diseases
1
Gastric Cancer With Liver Metastases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Breast Neoplasms, Male
1
Adenocarcinoma
1
Interventions
sotigalimab
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Rectal Adenocarcinoma
×
Immunotherapy
×
30 days
×
Clear all
NCT07596290
2026-05-22
RADICAL
Beijing Friendship Hospital
Phase 2/3
Not yet recruiting
342 enrolled